E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/6/2005 in the Prospect News Biotech Daily.

Bear Stearns reiterates market outperform for ev3

ev3, Inc. was maintained by Bear Stearns analyst Rick Wise at a market outperform rating, with a price target maintained at $23 per share. Bear Sterns said third-quarter revenue performance increased its confidence that the company's growth drivers in peripheral stents and neurovascular devices remain in good shape. Shares of the Plymouth, Minn.-based ev3 were down $.051, or 2.90%, at $17.08 on volume of 441,141 shares versus the three-month running average of 188,200 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.